Huntington’s disease was long thought to be caused by the slow buildup of a toxic protein, but new research has reveale | ...

Huntington’s disease is an inherited neurological disorder causing movement, cognitive, and behavioral issues. Effective ...

HDBuzz reported live updates on Bluesky from the 2025 HD Therapeutics Conference. Read on for coverage of Day 1. #CHDI2025 ...

Prilenia Therapeutics is planning to file its Huntington’s disease ... HD address the symptoms of the disease, and pridopidine is vying to become the first drug approved to slow down its ...

A drug originally developed for high blood pressure could find a new use in the treatment of Huntington's disease, thanks to an artificial intelligence-based drug discovery programme at Spain's ...

Management of dysphagia in people with Huntington’s disease can be complicated. Many of the medications to help manage Huntington’s disease symptoms, such as antipsychotic medications and ...

The Orphan Drugs Market is experiencing significant growth due to increasing investment in rare disease research, regulatory incentives, and advancements in biotechnology. Orphan drugs are specialized ...

However, managing complications of Huntington’s disease can involve a combination of medications and supportive care. This article explores some of the most frequently asked questions about the ...

Announced alignment with the U.S. Food and Drug Administration (FDA) on key elements of the Accelerated Approval pathway for AMT-130 in ...